VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780281 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

367

Enrollment

NIH

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: VIR-7831
BIOLOGICAL: Placebo
BIOLOGICAL: Remdesivir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]